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the Generation of Cross-Reactive T Cells for Myelin
Antigens
Chandirasegaran Massilamany1, Francine Marciano-Cabral2, Bruno da Rocha-Azevedo3,
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Abstract
We recently reported that Acanthamoeba castellanii (ACA), an opportunistic pathogen of the central nervous system (CNS)
possesses mimicry epitopes for proteolipid protein (PLP) 139–151 and myelin basic protein 89–101, and that the epitopes
induce experimental autoimmune encephalomyelitis (EAE) in SJL mice reminiscent of the diseases induced with their
corresponding cognate peptides. We now demonstrate that mice infected with ACA also show the generation of crossreactive T cells, predominantly for PLP 139–151, as evaluated by T cell proliferation and IAs/dextramer staining. We verified
that PLP 139–151-sensitized lymphocytes generated in infected mice contained a high proportion of T helper 1 cytokineproducing cells, and they can transfer disease to naı̈ve animals. Likewise, the animals first primed with suboptimal dose of
PLP 139–151 and later infected with ACA, developed EAE, suggesting that ACA infection can trigger CNS autoimmunity in
the presence of preexisting repertoire of autoreactive T cells. Taken together, the data provide novel insights into the
pathogenesis of Acanthamoeba infections, and the potential role of infectious agents with mimicry epitopes to self-antigens
in the pathogenesis of CNS diseases such as multiple sclerosis.
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viral- and myelin basic protein (MBP)-specific peptide fragments
[7,8], but the direct causal links between these virus infections and
predisposition to MS have not been proved clinically in a large
number of cases [9–12]. A theme that has also being emerged
suggests that MS trigger may involve exposure to multiple
microbes [1], and their disease-mediation may involve more than
one mechanism, such as bystander activation, release of cryptic
epitopes, molecular mimicry and epitope spreading [13–15].
In our efforts to identify the disease-inducing microbial mimics
for CNS myelin antigens, we recently identified two novel epitopes
from Acanthamoeba castellanii (ACA) [16–18]. These are derived
respectively from rhodanese-related sulfur transferase (RST), and
nicotinamide adenine dinucleotide dehydrogenase subunit 2
(NAD) of Acanthamoeba. The corresponding mimics, designated
ACA 83–95 and NAD 108–120, bear identical residues, respectively, for proteolipid protein (PLP) 139–151 and MBP 89–101.
We showed that ACA 83–95 and NAD 108–120 induce
experimental autoimmune encephalomyelitis (EAE) reminiscent
of the diseases induced respectively with their cognate peptides
through the generation of cross-reactive T cells [16–18]. We

Introduction
Multiple sclerosis (MS) is a chronic demyelinating inflammatory
disease in which mononuclear cells (MNC) infiltrate the central
nervous system (CNS) leading to the loss of oligodendrocytes and
axonal degeneration [1]. There are no known etiological agents
identified as triggers of MS nor is there permanent cure. It is
widely believed that MS pathogenesis involves generation of
autoimmune responses to myelin antigens requiring the mediation
of T cells and B cells, but the underlying mechanisms are not wellunderstood [1,2]. Two factors have been implicated in the
predisposition to MS: a) genetic susceptibility and b) environmental microbes. The latter proposal has been supported by the
observations that exacerbations of MS attacks or temporal
alterations in the disease course occur after viral or bacterial
infections, such as, with Epstein Barr virus, Human Herpes virus-6
and Clostridium perfringens type B. These associations have been
made based on detection of microbial genomic material, and
antibodies in the brains or CSF of MS patients [3–6]. In addition,
peripheral blood MNC from MS patient subjects can also react to
PLOS ONE | www.plosone.org
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report here that SJL mice infected with trophozoites of ACA show
the generation of myelin-reactive T cells. Furthermore, lymphocytes obtained from ACA-infected mice contained high frequencies of T helper (Th) 1 cytokine-producing cells that have the
ability to transfer disease to naı̈ve recipients.

Peptides
Myelin and mimicry peptide pairs (PLP 139–151,
HSLGKWLGHPDKF; ACA 83–95, YFLLKWLGHPNVS:
53.18% similarity; and MBP 89–101, VHFFKNIVTPRTP;
NAD 108–120, VVFFKNIILIGFL: 46.15% similarity; identical
residues are underlined between peptide pairs); and Theiler’s
murine encephalomyelitis virus (TMEV) 70–86 (WTTSQEAFSHIRIPLP) were synthesized on 9-fluorenylmethyloxycarbonyl
chemistry (Neopeptide, Cambridge, MA). All peptides were
HPLC-purified (.90%), identity was confirmed by mass spectroscopy, and the peptides were dissolved in 16PBS as described
previously [16–18].

Materials and Methods
Ethics Statement
Three-to-four-week-old female SJL/J (H-2s) mice were obtained
from the Jackson Laboratory (Bar Harbor, ME). The mice were
maintained in accordance with the animal protocol guidelines of
the University of Nebraska-Lincoln, Lincoln, NE. The study was
conducted in accordance with National Institutes of Health
guidelines for the use of experimental animals, and the protocols
were specifically approved by the University of Nebraska-Lincoln
Institutional Animal Care and Use Committee (permit number:
A3459-01; protocol # 454 and 659).

Proliferation Assay
Seven groups of mice were infected with ACA (56103), and T
cell proliferative responses were measured using cells obtained
from a pool of spleens and the draining lymph nodes (LN: cervical,
mandibular axillary, and inguinal), hereafter designated ‘lymphocytes’, from ACA-infected animals. Where indicated, CD4 or CD8
T cells were purified from lymphocytes harvested from infected
mice using CD4 or CD8 T lymphocyte enrichment kits (BD
Biosciences, San Jose, CA). Cells were stimulated with PLP 139–
151, ACA 83–95, MBP 89–101, NAD 108–120 or TMEV 70–86
(control) at a cell density of 56106 cells/ml for two days in growth
medium containing 16RPMI medium supplemented with 10%
fetal calf serum, 1 mM sodium pyruvate, 4 mM L-glutamine,
16each of non-essential amino acids and vitamin mixture, and
100 U/ml penicillin-streptomycin (Lonza, Walkersville, MD). In
experiments involving CD4 T cells or CD8 T cells, splenocytes
harvested from naı̈ve SJL mice were irradiated (3000 rads; Rad
Source, Suwanee, GA); loaded with peptides, and used as antigen
presenting cells (APCs). After pulsing with tritiated 3[H] thymidine
(1 mCi/well; MP Biomedicals, Santa Ana, CA) for 16 hours,
proliferative responses were measured as counts per minute (cpm)
using the Wallac liquid scintillation counter (Perkin Elmer,
Waltham, MA). In some experiments, infected mice were injected
with lipopolysaccharide (LPS) on day 20 and day 31 postinfection
(25, 10 mg/mouse respectively) and the animals were euthanized
on day 64 postinfection to purify CD4 T cells for proliferation
assay.

Propagation of ACA, Infection Procedure, and Clinical
Assessment
Human brain-isolate of ACA (strain 50494; ATCC, Manassas,
VA) was grown in peptone-yeast extract-glucose medium (PYG
medium, ATCC) in 75 cm2 flask at 25uC for four days. After
replacing the medium, the trophozoites were grown for three
additional days, and the adhered trophozoites were then harvested
by gentle tapping and pipetting and subcultured for two days.
Trophozoites were collected as above, and after washing twice, the
pellet was resuspended in 16Page’s saline that was warmed to
room temperature (RT), and viability was confirmed [19]. For
infection studies, mice were anesthetized using isoflurane and the
indicated number of trophozoites was administered in 20 ml
volume by instilling 10 ml into each nostril [20–22]. The animals
that received only Page’s saline served as controls.

Histopathology
Animals were euthanized on indicated days, and brain and
spinal cords were collected in 10% phosphate buffered formalin
for histology [17,23]. After fixation, brain and spinal cord sections
were processed routinely for paraffin embedment and sections
stained with hematoxylin and eosin (H and E). The slides were
evaluated by a neuropathologist who was blinded to treatment.
The sections were scored for lesion type, and severity, and counts
of inflammatory foci were determined in parenchyma and
leptomeninges [17]. Total scores were obtained by adding counts
of inflammatory foci in both meninges and parenchyma.
Inflammation was primarily classified as lymphocytic, suppurative,
or mixed [17]. All histological evaluations were performed by
board-certified pathologists.

Creation of IAs/Dextramers, and Enumeration of the
Frequencies of Antigen-specific T cells by Flow
Cytometry
To determine the frequency of antigen-specific T cells, IAs/PLP
139–151, ACA 83–95 and TMEV 70–86 dextramers were created
as described [17]. Briefly, the soluble IAs monomers expressed in
baculovirus were biotinylated using biotin protein ligase at a
concentration of 25 mg/10 nmol of substrate (Avidity, Denver,
CO). To prepare dextramers, biotinylated IAs monomers were
coupled to activated dextran backbones (kindly provided by
Immudex, Copenhagen, Denmark) at 1:20 molar ratio in 16Tris
Hcl 0.05 M, pH 7.2 for 30 minutes at RT as described previously
[24]. Lymphocytes obtained from nine groups of ACA-infected
(16103) mice were stimulated with PLP 139–151 or ACA 83–95
(50 mg/ml) for two days. Viable cells harvested on day 8 were
incubated with allophycocyanin-conjugated IAs dextramers at RT
for two hours [24]. After washing twice, cells were stained with
anti-CD4 and 7-AAD and acquired by FC. The frequency of
dextramer-positive cells was then enumerated in live (7-AAD2)
CD4+ population.

Immunophenotyping
Two groups of mice were infected with ACA (16103), and the
animals showing neurological signs were sacrificed to harvest
brains and spinal cords. The tissues were processed to obtain
MNC by percoll density-gradient separation [24], and the cells
were stained with cocktails of antibodies for various immune cell
markers, specifically, T cells (CD3, CD4 and CD8) and non-T
cells (B220, CD11b, CD11c, GR1 and CD49b) (all antibodies
from eBioscience, San Diego, CA), and 7-aminoactinomycin-D (7AAD; Invitrogen, Carlsbad, CA). After acquiring by flow
cytometry (FC) (FACSCalibur, BD Biosciences, San Diego, CA),
percentages of cells positive for each marker were determined in
the live (7-AAD2) population using Flow Jo software (Tree Star,
Ashland, OR).
PLOS ONE | www.plosone.org
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Intracellular Cytokine Analysis

Statistics

We determined the frequencies of Th1 (interferon [IFN]- c),
Th2 (interleukin [IL]-4, and IL-10), and Th17 (IL-17A, IL-17F,
and IL-22) cytokine-producing cells based on intracellular staining
by FC [17,25]. Briefly, lymphocytes harvested from five groups of
ACA-infected (16103) animals were stimulated with peptides
(20 mg/ml) for two days, and the cultures were maintained in IL-2
medium. Viable cells harvested on day 5 or lymphocytes obtained
from naı̈ve mice, were stimulated for five hours with phorbol 12myristate 13-acetate (PMA) (20 ng/ml) and ionomycin (300 ng/
ml) (Sigma-Aldrich, St. Louis, MO) in the presence of monensin
2 mM (Golgi stop, BD Pharmingen, San Diego, CA). After
staining with anti-CD4 and 7-AAD, cells were fixed, permeabilized and stained with cytokine antibodies or isotype controls
(eBioscience). The frequency of cytokine-secreting cells was then
determined in the live (7-AAD2) CD4+ subset by FC [17].

Wilcoxon rank sum test was used to compare differences in the
severity of clinical and histological EAE in animals infected with or
without PLP 139–151 priming. Differences in T cell proliferation
and frequencies of cytokine-producing cells were analyzed by
student’s t. p#0.05 values were considered significant.

Results
Establishment of ACA-induced CNS Disease in SJL Mice
To delineate autoimmune events in ACA infection, we used
human-isolate of Acanthamoeba, which has been previously shown to
induce granulomatous encephalitis in mice [20,22]. In a doseresponse study, we noted that high doses (16105 and above)
resulted in more than 66% mortalities within 10 days postinfection, while the animals that received low doses (16104 and below)
tolerated well and the mortalities were low (4/28, 14.3% with
16103; 2/12, 16.6% with 16104). Nonetheless, regardless of dose,
most of the infected animals showed general weakness, loss of body
weight, and respiratory distress during the initial acute attack
within approximately seven days postinfection, followed by
neurological signs. These include, circling, trunk ataxia or paresis
of the hind limbs with or without hyperactivity, dog-sitting posture
with laterally extended hind limbs, twirling of neck (head-tilt), and
loss of balance. Some of these signs such as, circling, ataxia,
paresis, and twirling of neck have also been described in EAE mice
[29].
We next evaluated CNS tissues for inflammatory changes. As
shown in figure 1A, both meninges and parenchyma in the brains
of majority of infected animals (60%) contained wide-spread
perivascular lymphocytic cuffs. The animals affected with acute
disease showed lesions mainly in the olfactory/frontal lobes; the
infiltrates consisted of macrophages and lymphocytes, suggestive of
granulomatous inflammation (Figure 1A). In contrast, only a few
mice (10.7%) showed inflammation in the spinal cords. Likewise,
staining with luxol fast blue did not reveal changes indicative of
demyelination, although occasional myelin-disruption was evident
(data not shown). Since most of the animals (more than 80%) that
received a dose of up to 16104 survived the acute phase and
showed histological evidence of inflammation, we chose the dose
to be less than 16104 to determine autoreactive T cell responses
during the course of ACA infection.
We then characterized the inflammatory cells using MNCs
purified from the brains and spinal cords of ACA-infected mice. As
shown in figure 1B, the infiltrates were comprised of both T cells
and non-T cells, with T cells accounting for ,51%, whereas nonT cells were represented by macrophages, dendritic cells,
neutrophils, B cells and natural killer (NK) cells. Notably, the
proportion of both CD4 and CD8 T cells were similar (26% vs.
25.6% respectively) suggesting that they may have a role in
disease-mediation.

Adoptive Transfer Experiments
Three groups of mice were infected with ACA (16103) and after
15 days, the animals were sacrificed and cell suspensions were
prepared from lymphoid tissues as above. We used two protocols
to generate primary T cell cultures: (i) cells were stimulated with
concanavalin-A (con-A, 1 mg/ml) for two days. After 48 hours,
viable cells harvested by ficoll density-gradient centrifugation
(1006106/mouse) were administered i.p. into groups of naı̈ve SJL
mice; and (ii) cells were stimulated with PLP 139–151 (20 mg/ml)
for two days, and the cells were maintained in growth medium
containing IL-2 for three more days. On day 5 poststimulation,
viable cells (506106/mouse) were administered i.p. into groups of
naı̈ve SJL mice. Pertussis toxin (PT; 100 ng; List Biological
laboratories, Campbell, CA) was administered i.p. on days 0 and 2
posttransfer, and the animals were monitored for clinical disease.
At termination, animals were euthanized, and CNS tissues were
collected for histology [16–18].

Induction of EAE by ACA Infection in Animals Primed
with PLP 139–151
Three groups of SJL mice were primed with suboptimal doses of
PLP 139–151 (2.5 or 10 mg/mouse) in complete Freund’s adjuvant
(CFA). Seven days later, one group of mice from each group were
infected with ACA (16103 trophozoites) by intranasal administration as described above, while the other, uninfected group,
served as control. We also used two other control groups namely,
saline (16 Page’s saline)- and CFA-recipients (uninfected and
infected). The animals were monitored for clinical signs of EAE or
encephalitis and scored until day 60, and at termination, brains
and spinal cords were collected for histology. The scoring scale
used to evaluate clinical signs of EAE was as described previously
[17,26]: 0 - healthy; 1 - limp tail or hind limb weakness but not
both; 2 - limp tail and hind limb weakness; 3 - partial paralysis of
hind limbs; 4 - complete paralysis of hind limbs; and 5 - moribund
or dead.

SJL Mice Infected with ACA show the Generation of
Myelin-reactive CD4+ T cells
Based on our previous data with ACA 83–95- and NAD 108–
120-induced EAE, we hypothesized that ACA infection leads to
the generation of cross-reactive cells for PLP 139–151 and MBP
89–101. To test this hypothesis, groups of mice were infected with
ACA, and on day 30 postinfection, splenocytes were used to
measure proliferative responses to myelin and ACA antigens. The
respective peptide pairs were: PLP 139–151 vs. ACA 83–95 and
MBP 89–101 vs. NAD 108–120. Expectedly, cells from ACAinfected mice responded in a dose dependent manner to both the
amoebic peptides, ACA 83–95 (Figure 2, top left panel) and NAD

Detection of ACA Genomic DNA by PCR
Total DNA was extracted from the brains of mice that received
Con-A- or PLP 139–151-stimulated cells, and the DNA was
subjected for PCR analysis using ACA-specific primers (forward,
59-GGCCCAGATCGTTTACCGTGAA-39);
reverse,
59TCTCACAAGCTGCTAG GGAGTCA-39) to yield an
,500 bp amplicon of the small subunit of 18S rDNA as previously
described [27,28]. The PCR products were resolved in 1%
ethidium bromide-stained agarose gel electrophoresis.

PLOS ONE | www.plosone.org
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Figure 1. Evaluation of CNS inflammation in mice infected with ACA. (A) Histological evaluation. SJL mice were infected intranasally with
ACA trophozoites (16103) under isoflurane anesthesia. Brains and spinal cords were harvested upon termination of the experiment, and the tissues
were processed for CNS inflammation by H and E staining. Brain: Perivascular cuffing of lymphocytes (arrows) and granuloma-like lesions
(arrowheads) composed of macrophages and lymphocytes. Spinal cord: Perivascular cuffing of lymphocytes in the leptomeninges (arrows). Original
magnification, 6400 (bar = 20 mm). (B) Immunophenotyping. Groups of mice were infected with ACA as above, and animals showing neurological
signs were killed on day 10 to harvest brains and spinal cords. The tissues were processed to obtain MNC by Percoll density-gradient separation, and
the cells were stained with cocktails of antibodies for the indicated immune cell markers and 7-AAD. After acquiring the cells by flow cytometry (FC),
percentages of various cell types were determined in the live (7-AAD2) cell population. Mean 6 SEM values from two individual experiments
involving two to three mice in each are shown.
doi:10.1371/journal.pone.0098506.g001

108–120 (Figure 2, top right panel) with a difference of , two-fold
higher than that was observed with the control peptide (TMEV
70–86). Similarly, cells also responded to the myelin peptide, PLP
139–151 (Figure 2, top left panel) with a 1.6-fold difference, but
such a response was lacking for MBP 89–101 (Figure 2, top right
panel). These findings suggest that RST and NAD, the respective
protein sources for ACA 83–95 and NAD 108–120 are naturally
processed, and the peptides are presented to the immune system.
Of note, aged SJL mice have a tendency to carry PLP-reactive T
cells in their naı̈ve periphery [30]. Our studies involved young
mice of 3 to 4 weeks old, in which, we did not observe the presence
of endogenously-derived PLP-reactive T cells (figure S1). Thus,
our data suggest that ACA infection has led to the appearance of
PLP-reactive T cells.
Further, we verified whether the reactivity to myelin antigens
lies in CD4 or CD8 T cell compartment, since the CNS tissues
from ACA-infected mice had similar proportions of CD4 and CD8
T cells (Figure 1B), and infiltrations were predominantly seen in
the brains, and not in the spinal cords similar to those reported in
PLOS ONE | www.plosone.org

MBP-specific CD8 T cell-mediated EAE in C3HeB/FeJ mice
[31,32]. To verify this, CD4 or CD8 T cells were purified from
ACA-infected mice, and their proliferative responses to myelin and
amoebic antigens were tested as above. We noted that the antigenreactivity was confined only to CD4 T cells (Figure 2, middle
panels) but not CD8 T cells (Figure 2, bottom panels), although, in
some experiments, low-grade responses were noted for MBP 89–
101, but the results were not consistent (data not shown).
Expectedly, CD4 T cells reacted to the amoebic peptides, ACA
83–95 (four-fold; Figure 2, middle left panel) and NAD 108–120
(three-fold; Figure 2, middle right panel), and a proportion of
ACA-sensitized CD4 T cells also responded to PLP 139–151 (2.5fold; Figure 2, middle left panel), but the response to MBP 89–101
was absent (Figure 2, middle right panel) leading us to determine
their antigen-specificity.
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Figure 2. ACA infection leads to the generation of PLP 139–151-reactive T cells. Top panels: Groups of SJL mice were infected intranasally
with ACA trophozoites (56103) and after 30 days, the mice were killed and spleens were harvested to prepare single cell suspensions. Cells were
stimulated with PLP 139–151 or ACA 83–95 (top left panel), MBP 89–101 or NAD 108–120 (top right panel) for two days followed by pulsing with 3[H]
thymidine, the incorporation of which was measured as cpm 16 hours later. TMEV 70–86, control. Mean 6 SEM values from three individual
experiments involving one mouse in each are shown. Middle and bottom panels: Lymphocytes were obtained from infected animals on day 10 postinfection and CD4 or CD8 T cells were then purified. Cells were stimulated with PLP 139–151 or ACA 83–95 (middle- and bottom left panels), MBP 89–
101 or NAD 108–120 (middle- and bottom right panels) in the presence of irradiated APCs, and proliferative responses were measured as above.
TMEV 70–86, control. Mean 6 SEM values from one of the four individual experiments involving a group of five mice in each are shown.
doi:10.1371/journal.pone.0098506.g002

infected mice. We assessed the frequencies of cytokine-producing
CD4 T cells by intracellular staining [16–18]. These analyses
included a panel of cytokines for Th1 (IFN-c), Th2 (IL-4 and IL10), and Th17 (IL-17A, IL-17F, and IL-22) cells. In both PLP
139–151- and ACA 83–95-sensitized cultures, cells capable of
producing all the cytokines tested were present (Figure 4), but their
frequencies differed in the order of Th1 (IFN-c).Th2 (IL-4+ IL10) or Th17 (IL-17A+IL-17F+IL-22) cells (Figure 4; see inset). By
deriving the ratios between the three Th cell subsets (Th1/Th2
and Th1/Th17), it was evident that the frequencies of IFN-cproducing cells were higher by three-to-four-fold than Th2- or
Th17-cytokine-producing cells (p,0.02). The cytokine responses
are attributable to antigen-stimulations because lymphocytes
obtained from naive SJL mice contained a negligible proportion
of cytokine-producing cells (IFN-c: 0.2%, Figure 4). The data
suggest that ACA infection results in the generation of predominantly Th1-, but to a lesser extent, Th17 cytokine-producing cells,
which are generally implicated in the development of organspecific autoimmunity.

Cross-reactive T cell Responses Induced with ACA are
Antigen-specific
To determine the antigen-specificity of cells that react with
ACA and myelin antigens, we created major histocompatibility
complex class II/IAs dextramers for ACA 83–95 and PLP 139–
151 as described previously [24]. Lymphocytes were harvested
from ACA-infected animals, and the cells were stimulated with
ACA 83–95 or PLP 139–151, in which, frequencies of antigenspecific cells were enumerated by FC. As depicted in figure 3, we
noted that the mean frequency of ACA-specific cells in ACA 83–
95-sensitized cultures was found to be 0.2860.06% as opposed to
0.4660.03% for PLP 139–151. Conversely, when the cells were
stimulated with PLP 139–151, the mean frequencies of PLPspecific cells were estimated to be higher (0.7860.09%) than that
of ACA 83–95 (0.2060.03%). The dextramer staining was
specific, since the binding with control (TMEV 70–86) dextramers
was negligible. The data suggest that ACA infection leads to the
generation of T cells that cross-react with both amoebic and
myelin antigens.

Myelin Antigen-reactive Lymphocytes Generated in ACAinfected Mice Induce CNS Autoimmunity in Naı̈ve
Recipients

Myelin-reactive T cells Generated in ACA-infected Mice
Contain High Frequencies of Th1 Cytokine-producing
Cells

Based on the finding that antigen-sensitized lymphocytes
generated in ACA-infected animals contained cells capable of
producing Th1 and Th17 cytokines, we hypothesized that they

We used cytokines as readouts to evaluate the pathogenic
potential of PLP 139–151-reactive T cells generated in ACA-

PLOS ONE | www.plosone.org
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Figure 3. Cross-reactive T cell responses induced by ACA infection are antigen-specific. SJL mice were infected with ACA (16103) and
after 21 days, the animals were killed; lymphocytes were prepared. Cells were stimulated with PLP 139–151 or ACA 83–95 for two days and the
cultures were maintained in IL-2 medium. Cells were harvested on day 8 poststimulation with peptides, and stained with IAs/dextramers followed by
anti-CD4 and 7-AAD. After acquiring the cells by FC, frequencies of dextramer-positive cells were determined in the live (7-AAD2) CD4 subset. Mean
6 SEM values obtained from nine independent experiments involving three to five mice in each are shown.
doi:10.1371/journal.pone.0098506.g003

Figure 4. Antigen-sensitized lymphocytes from ACA-infected mice contain predominantly Th1 cytokine-producing cells. Groups of
SJL mice were infected with ACA (16103). After 21 days, mice were killed, and lymphocytes were prepared. Cells were stimulated with PLP 139–151 or
ACA 83–95 for two days and the cultures were maintained in IL-2 medium. Cells harvested on day 5 from the above cultures or those obtained from
naı̈ve mice were stimulated with PMA (20 ng/ml) and ionomycin (300 ng/ml) for ,5 hours in the presence of 2 mM monensin followed by staining
with anti-CD4 and 7-AAD. After fixation and permeabilization, cells were stained with cytokine antibodies and acquired by FC. Frequencies of
cytokine-producing cells were then analyzed in the live (7-AAD2) CD4 subset. Inset: The combined frequencies of Th1 (IFN-c), Th2 (IL-4+ IL-10) and
Th17 (IL-17A+IL-17F+IL-22) cytokine-producing cells were calculated and compared between groups. Mean 6 SEM values obtained from five
independent experiments involving two mice in each are shown.
doi:10.1371/journal.pone.0098506.g004
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We asked whether LPS-administration into animals that were
recovered from ACA infection can promote the induction of EAE.
ACA-infected mice were injected with LPS on day 21 and day 30
postinfection, and the animals were monitored for clinical signs of
EAE. Contrary to our expectations, LPS-treatment did not lead to
EAE during the observation period of ,30 days. To verify
whether this lack of disease induction is due to the absence of
myelin-reactive T cells, we purified CD4 T cells from LPS-treated
animals, and evaluated their responses to amoebic and myelin
antigens using two peptide pairs (ACA 83–95/PLP 139–151 and
NAD 108–120/MBP 89–101). We observed dose-dependent
responses to both ACA 83–95 and PLP 139–151 as expected
(Figure 7: left panel). Importantly, we also noted reactivity to MBP
89–101 in conjunction with the appearance of NAD 108–120reactive T cells (Figure 7, right panel). Such reactivity to MBP 89–
101 was absent in the infected animals that did not receive LPS
(figure S3). Thus, our data support the notion that exposure to
microbial infections irrelevant to CNS can lead to nonspecific
activation of autoreactive T cells through the mechanism of
bystander activation.

can transfer disease into naı̈ve recipients. To test this hypothesis,
we isolated lymphocytes from ACA-infected mice and after
expanding with con-A, cells were transferred into naı̈ve SJL mice.
Clinically, the recipients did not show clinical signs of EAE, but
histologically, both brains and spinal cords showed inflammatory
infiltrates. Although, immunophenotyping was not performed,
inflammatory cells were deemed to be primarily lymphocytes and
macrophages based upon morphology (Figure 5A, Table 1).
Similar results were also noted in mice that received PLP 139–151stimulated lymphocytes (Figure 5B, Table 1). These inflammatory
changes were not due to the presence of ACA, if any, in the
transfused cells, as the CNS tissues did not reveal the presence of
ACA genomic DNA as evaluated by PCR analysis [27,28] (figure
S2). We thus, demonstrated that the myelin-reactive T cells
generated in ACA-infected mice share the functional features of
encephalitogenic T cells, and contribute to CNS disease.

ACA Infection can Alter Susceptibility to CNS
Autoimmunity in Animals Primed with Suboptimal Doses
of PLP 139–151
To determine whether exposure to ACA can alter susceptibility
to CNS autoimmunity in the presence of preexisting repertoire of
autoreactive T cells, we immunized groups of mice with
suboptimal doses of PLP 139–151 (2.5 or 10 mg/mouse) and the
animals were monitored for EAE-signs after infecting them with
ACA (16103/mouse). Figure 6 shows that animals that were
primed with PLP 139–151, and later infected with ACA,
developed clinical EAE with a greater severity as compared to
the animals primed with PLP 139–151 alone, and the differences
were clear in animals that received 10 mg peptide/CFA emulsion.
We noted that the animals that received peptide/CFA emulsions
alone did not develop EAE even up to day 16 postimmunization
compared to those exposed to ACA (7.6%; 1/13 vs. 38.4%; 5/13)
(Figure 6, lower panel). The daily median EAE scores for the
group that received peptide/CFA alone remained less throughout
the course of the study compared to the mice that were primed
and infected with ACA (p = 0.037). The animals in control groups
(saline or CFA) that were infected with or without ACA did not
show EAE-signs (data not shown). Consistent with the clinical
EAE, brains and spinal cords also showed a tendency for
inflammatory foci to be increased in primed and infected mice
compared to the mice that received peptide emulsions alone
(Table 2). The data suggest that exposure to ACA can potentiate
susceptibility to CNS autoimmunity in the presence of preexisting
repertoire of autoreactive T cells.

Discussion
In this study, we provide four lines of evidence to demonstrate
that ACA infection can predispose to CNS autoimmunity in SJL
mice: a) mice infected with ACA show clinical and histological
evidence of CNS inflammation by generating cross-reactive T cells
for PLP139–151, b) ACA-sensitized lymphocytes have the ability
to produce Th1 cytokines but to a low degree, Th17 cytokines that
are known to be critical for induction of organ-specific autoimmune diseases [34], c) antigen-sensitized lymphocytes harvested
from infected mice can transfer disease to naı̈ve recipients, and d)
ACA infection can alter susceptibility to EAE in animals primed
with suboptimal doses of PLP 139–151.
EAE models generally have a limitation in that the disease is
induced artificially with peptide-CFA emulsions. Hence, the
immune events do not necessarily reflect those that can occur
under natural conditions within the CNS. It has been proposed
that exposure to environmental microbes can break self-tolerance
leading to the recognition of myelin antigens as foreign. To test
this hypothesis, it is critical to develop models that faithfully
replicate the events of an infectious agent that primarily infects
CNS, leading to the generation of autoimmunity secondarily, as
might occur in ACA infection.
Acanthamoeba are free-living amoebae that are ubiquitous in the
environment. Most healthy individuals carry Acanthamoeba-reactive
antibodies, suggesting constant exposure to amoebae [21,35,36].
In spite of the high prevalence of the amoebae, the incidence of
diseases caused by Acanthamoeba is very low. Non-opportunistically,
Acanthamoebae can induce keratitis in healthy humans, but as an
opportunistic pathogen, the amoebae can cause fatal encephalitis,
especially, in immunocompromised individuals and treatments are

Administration of LPS into ACA-infected Mice Leads to
the Generation of MBP 89–101-Reactive T cells
Microbial products such as LPS, bacterial DNA and unmethylated CpG’s have been shown to trigger autoimmunity by inducing
the generation of effector Th1 cells under certain conditions [33].

Table 1. Histologic evaluation of EAE in mice that received lymphocytes from ACA-infected mice.
No. of inflammatory foci{
Treatment

Incidence{ (%)

Meninges

Con-A

6/6 (100)

6.762.9

2.861.5

9.564.0

PLP 139–151

2/3 (66)

5.062.0

2.062.0

7.064.0

Parenchyma

Total

{
represents mice that showed histological disease.
doi:10.1371/journal.pone.0098506.t001
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Figure 5. Lymphocytes from ACA-infected mice induce CNS inflammation in naı̈ve mice. (A) Con-A-stimulated cells. Groups of SJL
mice were infected with ACA (16103) and the animals were killed 15 days postinfection, and lymphocytes were prepared. Cells were stimulated with
Con-A (1 mg/ml) for two days; viable cells were harvested and 1006106 cells were injected i.p. into naı̈ve mice. Brains and spinal cords were harvested
on day 30 posttransfer, and the tissues were processed for CNS inflammation by H and E staining. Arrows indicate perivascular cuffing. Original
magnification, 6400 (bar = 20 mm). (B) PLP 139–151-stimulated cells. Lymphocytes harvested as above were stimulated with PLP 139–151
(20 mg/ml) for two days and the cultures were maintained in IL-2 medium. Viable cells were harvested on day 5 poststimulation and 506106 cells
were injected i.p. into naı̈ve mice. Brains and spinal cords were harvested on day 45 posttransfer and processed for evaluation of CNS inflammation
by H and E staining. Arrows indicate perivascular cuffing. Original magnification, 6400 (bar = 20 mm).
doi:10.1371/journal.pone.0098506.g005

often ineffective [21,36–39]. We had recently reported that ACA
contains mimicry epitopes for PLP 139–151 and MBP 89–101,
and they induce EAE by generating corresponding cross-reactive
T cells in SJL mice [16–18,36]. These data prompted us to
establish ACA infection in SJL mice to study the autoimmune
events of Acanthamoeba infections.

Histological evaluation of CNS tissues obtained from ACAinfected mice revealed that brains but not spinal cords were
consistently affected, and the inflammatory foci predominantly
contained macrophages and lymphocytes. ACA is known to
induce granulomatous encephalitis accompanied with hemorrhagic necrosis, but most studies used ‘death’ as the end-point to

Table 2. Histological evaluation of CNS tissues obtained at termination from ACA-infected mice primed with or without PLP 139–
151.
No. of inflammatory foci{

Treatment groups
PLP 139–151 priming (mg)

Infection

Incidence (%)

Meninges

Parenchyma

Total
20.364.1

2.5

2

4/5 (80)

16.562.9

3.861.3

2.5

+

4/4 (100)

21.364.1

11.865.8

33.069.6

10

2

8/8 (100)

62.3629.7

71.1630.3

133.5650.8

10

+

7/8 (87.5)

85.0627.6

92.4634.9

176.0649.6

{

represents mice that showed histological disease.
doi:10.1371/journal.pone.0098506.t002
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Figure 7. LPS-treatment of animals recovered from ACA
infection leads to the generation of MBP 89–101-reactive T
cells. Groups of SJL mice were infected intranasally with ACA
trophozoites (7.56103) and on day 20 and day 31 postinfection, LPS
was administered. Animals were killed on day 64 postinfection and
lymphocytes were prepared to purify CD4 T cells. Cells were stimulated
for two days with irradiated APCs loaded with peptides: PLP 139–151 or
ACA 83–95 (left panel); and MBP 89–101 or NAD 108–120 (right panel).
After pulsing with 3[H]-thymidine for 16 hours, proliferation was
measured as cpm. TMEV 70–86 (control). Mean 6 SEM values
representing from one of the two experiments involving two mice in
each are shown.
doi:10.1371/journal.pone.0098506.g007

First, we verified that lymphocytes from infected animals
reacted to both ACA 83–95 and NAD 108–120, suggesting that
amoebic peptides are naturally processed and presented to the
immune system. However, we noted that PLP-reactive- but not
MBP-reactive T cells to be detected in the infected mice.
Nonetheless, when MBP-reactive T cells were verified at various
time points, day 5, 10, 15, 21, 30, and 82 postinfection, we noted
low magnitude of responses to MBP 89–101, but the responses
were not consistent. However, LPS-treatment of animals that
recovered from ACA infection led to the appearance of MBP 89–
101-reactive T cells but not EAE. We did not investigate whether
this lack of disease is due to the inability of MBP-reactive T cells to
infiltrate into the brains as intact BBB might have prevented their
migration into the CNS. Reports indicate dual role for LPS in
EAE pathogenesis in that the disease-severity could be suppressed
or augmented depending on the stage of disease. For example,
administration of LPS prior to EAE-induction led to the
amelioration of EAE [49,50]. Conversely, PLP 139–151-specific
T cell receptor transgenic EAE-resistant B10.S mice, developed
EAE spontaneously with LPS-treatment [51]. The diseaseinducing abilities of LPS have been ascribed to its effects on
APCs to upregulate costimulatory molecules, and secretion of
soluble factors like IL-12, independent of T cell receptorstimulation [33,52].
We next determined whether myelin-reactive T cells that
appear in ACA-infected animals are pathogenic, based on
cytokine analysis and adoptive transfer experiments. We noted
that lymphocytes from ACA-infected mice that are sensitized with
PLP 139–151 were comprised of predominantly Th1- and to a
lesser degree, Th17- and Th2 cytokine-producing cells. Although
antigen-sensitized lymphocytes harvested from infected mice
induced CNS inflammation in naı̈ve recipients, clinical EAE was
absent. Accumulated literature suggests that, while, both Th1 and
Th17 cytokines can mediate CNS autoimmunity, Th17 cytokines
appear to be indispensable, since IL-17- but not IFN- c-deficient
mice resist development of EAE [53,54]. Additionally, sequential
entry of Th cells may determine the outcome of EAE in that, Th1
cells migrate into the CNS prior to Th17 cells, which, then
promote chemotaxis, inflammation and demyelination [55,56].
Thus, the lack of typical EAE signs in animals that received
antigen-stimulated cells may be due to insufficient production of
Th17 cytokines. However, the observation that, ACA infection led

Figure 6. ACA infection alters susceptibility to EAE in mice
primed with suboptimal doses of PLP 139–151. Groups of SJL
mice were immunized with or without PLP 139–151 (2.5 or 10 mg/
mouse) in CFA. On day 7 post-immunization, the animals were infected
with ACA (16103) and the animals were monitored for clinical signs of
EAE and scored. Data represent mean EAE scores for a group of mice
pooled from two to three individual experiments.
doi:10.1371/journal.pone.0098506.g006

determine the pathogenicity [22,40–43]. The dose used in our
studies (16103) is ,1000-fold less than that in other studies
[22,43]; and this amount of amoebae also led to fewer deaths but
with no necrotic changes in the CNS. This suggests that the
severity of the CNS pathology is directly proportional to the dose
used to infect the mice. This notion is consistent with the finding
that trophozoites were detected in less than 15% (4/28) of mice
infected with 16103 ACA.
In EAE, there is a linear relationship between disease severity
and permeability of the blood brain barrier (BBB), such that loss of
BBB-integrity allows circulating immune cells and also soluble
factors into CNS, and vice versa, for CNS products [44,45].
Acanthamoeba can enter CNS by migrating through the olfactory
neuroepithelium and/or blood [36]. Regardless of route however,
the amoebae have to cross BBB paracellularly or transcellularly,
where BBB-disruption is believed to be mediated by contactdependent (via attachment) and contact-independent (via proteases) mechanisms [21,36,46–48]. Since, the inflammatory foci
were commonly noted in the brains (especially, olfactory/frontal
lobes), the tissue destruction most likely resulted from the damage
directly caused by ACA.
On the contrary, the presence of inflammatory changes in the
brains of infected mice, but in the absence of ACA trophozoites in
most of them (24/28:85.7%), indicates that the pathogenesis may
involve the mediation of cellular events. Based on our previous
data with ACA 83–95- and NAD 108–120 in EAE studies [16–
18,36], we reasoned that autoreactive T cells generated in
response to ACA infection can contribute to CNS pathology in
infected animals.
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to the induction of EAE in animals primed with suboptimal doses
of PLP 139–151, point to a possibility that the pre-existing
repertoire of autoreactive T cells as might occur in genetically
susceptible individuals may expand in response to Acanthamoeba
infections leading to CNS autoimmunity. Consistent with this
notion, the clinical EAE was apparent in the animals that received
10 mg of peptide as compared to those that received 2.5 mg. This is
likely because, Acanthamoeba carries a cross-reactive epitope for PLP
139–151, and as such, proportion of cross-reactive T cells are
expected to be more in animals injected with 10 mg than 2.5 mg of
peptide.
In summary, we demonstrate that ACA infection can lead to the
generation of encephalitogenic cross-reactive T cells by antigenic
mimicry, thus establishing a novel disease model to study CNS
autoimmune diseases like MS. ACA is ubiquitously present in the
environment worldwide, having been isolated from wide-range of
sources, including soil, water and eye-wash stations and as
contaminants; and the importance of ACA is increasingly being
recognized in the acquisition of nosocomial infections [21,36].
Although, no associations have been reported between ACA
infection and MS prevalence, MS has been considered in the
differential diagnosis of Acanthamoeba encephalitis [57]. Furthermore, serologic evidence suggests that, more than 50% of healthy
humans can carry Acanthamoeba-reactive antibodies and seropositivity occurred in the order of Caucasians followed by Hispanics
and African Americans [19,35,47,58,59]. In addition, T cells from
healthy individuals can react to Acanthamoeba antigens, and
antigen-specific T cell clones capable of secreting IFN-c have
been derived [60]. Likewise, peripheral blood MNC from
rheumatoid arthritis patients show proliferative responses to
Acanthamoeba, and amoebic encephalitis can occur in patients with
systemic lupus erythematosus; the significance of these findings is
not known [35,58,59,61]. Our data may present a compelling
rationale to investigate the role of ACA in MS-predisposition,
which we are currently investigating. Our preliminary results
indicate that cerebrospinal fluid samples obtained from MS
patients, but not from those with other neurological disorders,
show evidence of ACA-genomic material as evaluated by PCR
(unpublished observations). Further as we reported previously
[16], by deriving homology model for NAD 104–118 complexed
with human leukocyte antigen-DR2 molecule, NAD 104–118 has
the potential to induce cross-reactive T cells for human MBP 85–
99, which is recognized as one of the major immunodominant
epitopes in MS patients [62]. Demonstrating that CNS pathogens
of humans like ACA have a role in MS predisposition may create
opportunities to target the inciting agents of MS therapeutically.

Supporting Information
Figure S1 Analysis of endogenously derived PLP-reac-

tive T cells in naı̈ve SJL mice. (A) Proliferative response.
Splenocytes were prepared from naı̈ve SJL mice aged 3 to 4 weeks,
and the cells were stimulated with PLP 139–151 and TMEV 70–
86 (control) for two days. After pulsing with 3[H]-thymidine for 16
hours, proliferation was measured as cpm. Mean 6 SEM values
from three individual experiments involving two mice in each are
shown. (B) Dextramer staining. CD3+ T cells enriched from
naı̈ve mice were stained with PLP 139–151 or TMEV 70–86
(control) dextramers, anti-CD4 and 7-AAD. After acquiring the
cells by FC, frequencies of dextramer-positive cells were
determined in the live (7-AAD2) CD4 subset. Top panels,
representative FC plots. Bottom panel, mean 6 SEM values from
six experiments each involving one to three mice are shown.
(TIF)
Figure S2 PCR analysis of ACA genome in the brains of
naı̈ve recipients of cells derived from mice infected with
A. castellanii. Total DNA was extracted from the brains of mice
that received Con-A- or PLP 139–151-stimulated cells, generated
from animals infected with A. castellanii. After subjecting the DNA
for PCR analysis using A. castellanii-specific primers, the PCR
products were resolved in 1% agarose gel electrophoresis and
stained with ethidium bromide (n = 9).
(TIF)
Figure S3 Analysis of autoreactive T cells in mice
chronically infected with A. castellanii. SJL mice infected
with ACA trophozoites (206103) were euthanized 12 weeks
postinfection, and CD4 T cells were enriched. After stimulating
the cells with the indicated peptides in the presence of irradiated
APCs for two days, cells were pulsed with 3[H]-thymidine for 16
hours, and proliferation was then measured as cpm. TMEV 70–86
(control). Mean 6 SEM values from three individual experiments
are shown.
(TIF)
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